This prespecified secondary analysis of a randomized clinical trial investigates the pharmacokinetics of a 2-dose dalbavancin regimen and its association with clinical success among patients with complicated Staphylococcus aureus bacteremia.
JAMA Network Open published a clinical update in Research Highlights on 18 Apr 2026. The item focuses on Pharmacokinetics of Dalbavancin in Complicated Staphylococcus aureus Bacteremia. Open the detail page to review the full original feed content.